U.S. Hospital & Nursing Home Probiotics Market To Reach $305.2 Million By 2030

U.S. Hospital & Nursing Home Probiotics Market Growth & Trends

The U.S. hospital and nursing home probiotics market size is estimated to reach USD 305.2 million by 2030, expanding at a CAGR of 8.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growth in use of probiotics in healthcare institutions has created various new applications for the product, which is contributing toward development of this market.

Rising demand for natural and healthy products is encouraging manufacturers to include probiotics in their products, which is projected to propel demand in the coming years. Manufacturers are also currently involved in overall market development by creating awareness about the advantages of probiotics. For this purpose, they prefer a collaborative approach by entering into long-term partnerships with probiotic strain suppliers.

In U.S., the ratio of community hospital capacity per 1,000 residents was 2.5 beds per individual in 2014, while the average duration of stay was 5.5 days per hospital stay. Hospital care has witnessed substantial changes over the past four decades. This transformation can be attributed to several factors such as reform in payment systems, modification in practice patterns, shift in consumer preferences, and technological advancements in medical care.

In U.S., rural residents are facing more health problems than urban citizens. Some of the major factors behind poorer healthcare conditions in rural areas in the country are social and cultural differences, economic factors, and educational shortcomings. However, the rural segment is projected to witness the fastest growth rate over coming years owing to presence of various untapped markets, which is attracting healthcare institutions to open or expand their operational and distribution facilities.

 Request a free sample copy or view report summary: U.S. Hospital And Nursing Home Probiotics Market Report

U.S. Hospital & Nursing Home Probiotics Market Report Highlights

• The U.S. hospital & nursing home probiotic market is projected to reach USD 305.2 million by 2025 at an estimated CAGR of 8.7% from 2025 to 2030

• In October 2024, Probi announced the launch of the ‘Metabolic Health by Probi’ probiotic concept at the SupplySide West 2024 event held in Las Vegas. The product supports metabolic health, weight management, and cardiovascular health by targeting the key markers of metabolic syndrome, which is a condition linked to an increased risk of diabetes and cardiovascular diseases. The solution uses two proprietary strains, the Lactiplantibacillus plantarum 299v (LP299V) and the Lacticaseibacillus paracasei 8700:2, to address these issues while also promoting gut health.

• The share of the rural population reporting fair to poor physical health is nearly one and a half times the percentage of urban residents

• Lucrative opportunities in U.S. are bound to attract new entrants. However, massive investments required for carrying out R&D operations is a cause for concern for new entrants

• Some of the key companies present in the market are Bio-K Plus International Inc.; Probi AB; Dietary Pros, Inc.; i-Health, Inc.; and Probium LLC.

U.S. Hospital & Nursing Home Probiotics Market Segmentation

Grand View Research has segmented the U.S. hospital and nursing home probiotics market based on channel and function:

U.S. Hospital & Nursing Home Probiotics Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital

  • Number of Beds

    • 1-199

    • 200-299

    • 300-499

    • 500+

  • Payer

    • Medicare

    • Medicaid

    • Self-pay

    • Private

    • Others

  • Location

    • Rural

    • Urban

• Nursing Home

  • Number of Beds

    • Less than 50

    • 50-99

    • 100-199

    • 199+

  • Payer

    • Medicare

    • Medicaid

    • Dual

  • Ownership

    • Government

    • Profit

    • Non-profit  

U.S. Hospital & Nursing Home Probiotics Function Outlook (Revenue, USD Million, 2018 - 2030)

• Gut Health

• Immunity

• Wellness

• Others

List of Key Players in U.S. Hospital & Nursing Home Probiotics Market

• Bio-K+, a Kerry company

• American Lifeline Inc.

• Rising Pharmaceuticals

• BD

• Dietary Pros, Inc.

• Dr. Joseph Mercola

• i-Health, Inc.

• Probi

• Lallemand Inc.

• Chr. Hansen A/S, part of Novonesis

• Biocodex

• Probiotical S.p.A.

• Protexin